We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not prescribed

2 Jun 2006 By Robert Cyran

The UK pharma group is reportedly preparing to bid a whopping 21 times operating profit for Pfizer s nonprescription drugs business. Doing so would be a strategic and financial mistake. The company would be better off concentrating on discovering new drugs.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)